Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Incidence of Cancer in Adult patients with Congenital Heart Disease

Adults with congenital heart disease are exposed to cumulative radiation doses, from multiple catheterization procedures. Seeing as these patients are exposed since early age, the chance of stochastic effect due to radiation exposure are relatively higher than that of the elderly population.

Incidencia de cáncer en pacientes adultos con cardiopatías congénitas

It is clear the chance of incident cancer in adults with congenital heart disease is higher than that of the general population but, so far, there are no figures to estimate this association.


Read also: “Protective Shield RADPAD Reduces the Radiation Dose Received by Operators in the Cath Lab”.


The study population was obtained from the Quebec database. The study looked at cumulative doses during cardiac procedures for each patient until one-year prior cancer diagnosis.

 

The study included 24833 patients with congenital heart disease between 18 and 64 years from 1995 to 2009. After following up 250791 patients/year, researchers observed 602 cases of cancer at mean 55.4 years.

 

Cancer cumulative incidence at 64 years was estimated in 15.3% (CI 95%; 14.2-16.5).


Read also: “Radiation Exposure in Chronic Total Occlusions”.


Cancer patients had a bigger number of catheterization procedures than control patients. (1410 vs 921 every 1000 patients with congenital heart disease; p<0.0001).

 

Radiation was independently associated with cancer, both per procedure (OR: 1.08; CI 95%, 1.04-1.13) and per dose (OR: 1.10 per every 10 milliSieverts; CI 95%, 1.05 1.15).

 

Conclusion

This is the first large population-based study to look at the association between radiation exposure in cardiac procedures and the incidence of cancer in adults with congenital heart disease.

 

Editorial Comment

These findings should be confirmed by prospective studies to reinforce recommendations on radiation surveillance in a highly, early exposed population. This is vital if we are to standardize cancer prevention policies, currently non-existent. 

 

For now, physicians must ensure diagnostic and therapeutic procedures with the lowest possible radiation dose, without compromising quality.

 

Original title: Exposure to Low-Dose Ionizing Radiation from Cardiac Procedures and Malignancy Risk in Adults with Congenital Heart Disease Running.

Reference: Cohen et al. Circulation. 2017 Dec 21. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

TAVI in TAVI: Clinical and Hemodynamic Outcomes According to the Type of Prosthesis Used in TAVI-in-TAVI

With the expansion of TAVI to younger and lower surgical risk patients, bioprosthetic valve degeneration and the need for repeat interventions are expected to...

Percutaneous Closure of Patent Foramen Ovale in Patients Over 60 Years Old With Cryptogenic Stroke: A Safe and Effective Strategy?

Cryptogenic stroke accounts for up to one-third of all ischemic strokes and remains strongly associated with the presence of a patent foramen ovale (PFO),...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...